|本期目录/Table of Contents|

[1]王耕桐,冯喜英,刘洪千,等.阻塞性睡眠呼吸暂停低通气综合征相关血清学的研究进展[J].中华肺部疾病杂志,2022,(01):112-115.[doi:10.3877/cma.j.issn.1674-6902.2022.01.034]
点击复制

阻塞性睡眠呼吸暂停低通气综合征相关血清学的研究进展(PDF)

《中华肺部疾病杂志》[ISSN:1006-6977/CN:61-1281/TN]

卷:
期数:
2022年01期
页码:
112-115
栏目:
综述
出版日期:
2022-02-20

文章信息/Info

Title:
-
作者:
王耕桐1; 冯喜英2; 刘洪千2; 赵玲莉3
810000 西宁,青海大学1 810000 西宁,青海大学附属医院呼吸与危重症学科2 检验科3
Author(s):
-
关键词:
低通气综合征; 睡眠呼吸暂停; 阻塞性;  血清学
Keywords:
-
分类号:
R563
DOI:
10.3877/cma.j.issn.1674-6902.2022.01.034
摘要:
-
Abstract:
-

参考文献/References:

1 王 玮. 无创通气是睡眠呼吸暂停低通气的首选和主要治疗手段[J/CD]. 中华肺部疾病杂志(电子版), 2014, 7(6): 614-616.
2 朱 悦, 董佳慧, 孙耕耘. 阻塞性睡眠呼吸暂停低通气综合征患者无创呼吸机治疗进展[J/CD]. 中华肺部疾病杂志(电子版), 2019, 12(2): 233-236.
3 Gautier-veyret E, Van Noolen L, Levy P, et al. Could the thromboxane A2 pathway be a therapeutic target for the treatment of obstructive sleep apnea-induced atherosclerosis? [J]. Prostaglandins Other Lipid Mediat, 2015, 121(Pt A): 97-104.
4 Rahangdale S, Yeh SY, Novack V, et al. The influence of intermittent hypoxemia on platelet activation in obese patients with obstructive asleep apnea[J]. J Clin Sleep Med, 2011, 7(2): 172-178.
5 Chu SG, Becker RC, Berger PB, et al. Mean platelet volume as a predictor of cardiovascular risk: a systematic review and meta-analysis [J]. J Thromb Haemost, 2010, 8(1): 148-156.
6 Sokucu SN, Ozdemir C, Dalar L, et al. Is mean platelet volume really a severity marker for obstructive sleep apnea syndrome without comorbidities? [J]. Pulm Med, 2014, 2014: 754839.
7 Pan QX, Su ZJ, Zhang JH, et al. A comparison of the prognostic value of preoperative inflammation-based scores and TNM stage in patients with gastric cancer.[J]. Onco Targets Ther, 2015, 8: 1375-1385.
8 Al-halawani M, Naik S, Chan M, et al. Neutrophil-to-lymphocyte ratio decreases in obstructive sleep apnea treated with mandibular advancement devices [J]. Sleep Breath, 2018, 22(4): 989-995.
9 Oyama JI, Nagatomo D, Yoshioka G, et al. The relationship between neutrophil to lymphocyte ratio, endothelial function, and severity in patients with obstructive sleep apnea[J]. J Cardiol, 2016, 67(3): 295-302.
10 Sunbul M, Sunbul EA, Kanar B, et al. The association of neutrophil to lymphocyte ratio with presence and severity of obstructive sleep apnea[J]. Bratislavske Lekarske Listy, 2015, 116(11): 659-661.
11 Kassi E, Adamopoulos C, Basdra EK, et al. Role of vitamin D in atherosclerosis[J]. Circulat, 2013, 128(23): 2517-2531.
12 Mete T, Yalcin Y, Berker D, et al. Obstructive sleep apnea syndrome and its association with vitamin D deficiency [J]. J Endocrinol Invest, 2013, 36(9): 681-685.
13 Kerley CP, Hutchinson K, Bolger K, et al. Serum vitamin D is significantly inversely associated with disease severity in caucasian adults with obstructive sleep apnea syndrome [J]. Sleep, 2016, 39(2): 293-300.
14 Mete T, Yalcin Y, Berker D, et al. Obstructive sleep apnea syndrome and its association with vitamin D deficiency [J]. J Endocrinol Invest, 2013, 36(9): 681-685.
15 Kerley CP, Hutchinson K, Bramham J, et al. Vitamin D improves selected metabolic parameters but not neuropsychological or quality of life indices in OSA: A pilot study [J]. J Clin Sleep Med, 2017, 13(1): 19-26.
16 Mazur A, Maier JAM, Rock E, et al. Magnesium and the inflammatory response: potential physiopathological implications.[J]. Arch Biochem Biophys, 2007, 458(1): 48-56.
17 Karamanli H, Kizilirmak D, Akgedik R, et al. Serum levels of magnesium and their relationship with CRP in patients with OSA [J]. Sleep Breath, 2017, 21(2): 549-556.
18 Jeroen HF de Baaij, Joost GJ Hoenderop, René JM Bindels. Magnesium in man: implications for health and disease[J]. Physiol Rev, 2015, 95(1): 1-46.
19 Sunnetcioglu A, Alp HH, Sertogillarindan B, et al. Evaluation of oxidative damage and antioxidant mechanisms in COPD, lung cancer, and obstructive sleep apnea syndrome [J]. Respir Care, 2016, 61(2): 205-211.
20 Ye L, Qian Y, Li Q, et al. Serum romo1 is significantly associated with disease severity in patients with obstructive sleep apnea syndrome [J]. Sleep Breath, 2018, 22(3): 743-748.
21 陈长强, 顾志冬, 樊绮诗. 血清淀粉样蛋白A在疾病应用中的研究进展[J]. 检验医学, 2012, 27(9): 82-85.
22 Svatikova A, Wolk R, Shamsuzzaman AS, et al. Serum amyloid a in obstructive asleep apnea [J]. Circulation, 2003, 108(12): 1451-1454.
23 刘仲仲, 段康丽, 吴松笛. 血清S100B蛋白的检测方法综述[J]. 实验与检验医学, 2016, 34(4): 461-465.
24 Rebecca V Vince, Bryna Chrismas, Adrian W Midgley, et al. Hypoxia mediated release of endothelial microparticles and increased association of S100A12 with circulating neutrophils[J]. Oxid Med Cell Longev, 2009, 2(1): 2-6.
25 Donato R. Intracellular and extracellular roles of S100 proteins [J]. Microsc Res Tech, 2003, 60(6): 540-551.
26 Demirci Saglam G, Zamani A, Yosunkaya S, et al. Serum S100A12 and S100B proteins are independent predictors of the presence and severity of obstructive sleep apnea [J]. Turk J Med Sci, 2019, 49(3): 746-754.
27 Shinsuke Oh-I, Hiroyuki Shimizu, Tetsurou Satoh, et al. Identification of nesfatin-1 as a satiety molecule in the hypothalamus[J]. Nature, 2006, 443(7112): 709-712.
28 Sirpa Leivo-Korpela, Lauri Lehtimäki, Mari Hämälainen, et al. Adipokines NUCB2/nesfatin-1 and visfatin as novel inflammatory factors in chronic obstructive pulmonary disease [J]. Mediators Inflamm, 2014, 2014, 232167.
29 Omer Araz, Elif Yilmazel Ucar, Emrullah Dorman, et al. Is There a relationship between obstructive sleep apnea syndrome severity and nesfatin-1? [J]. Respirat, 2015, 90(2): 105-110.
30 Tomas G. Hepcidin and iron regulation, 10 years later [J]. Blood, 2011, 117(17): 4425-4433.
31 Alberto P, Stefania G, Raffaella M, et al. Modulation of hepcidin production during hypoxia-induced erythropoiesis in humans in vivo: data from the HIGHCARE project[J]. Blood, 2011, 117(10): 2953-2959.
32 Leida T, Ilza S. Iron metabolism: current facts and future directions[J]. Biochemia Medica, 2012, 22(3): 311-328.
33 Noémie Le Tallec-Estève, Chloé R, Benoit D, et al. Transferrin saturation is independently associated with the severity of obstructive sleep apnea syndrome and hypoxia among obese subjects [J]. Clin Nutr, 2021, 40(2): 608-614.
34 Berryman DE, Glad CAM, List EO, et al. The GH/IGF-1 axis in obesity: pathophysiology and therapeutic considerations.[J]. Nat Rev Endocrinol, 2013, 9(6): 346.
35 Wang X, Wang YF, Cai ZC, et al. Alterations of IGF-1, complement C3 and superoxide dismutase in patients with moderate-to-severe obstructive sleep apnea hypopnea syndrome[J]. Biomark Med, 2018, 12(3): 217-228.
36 David G, Leila KG, Alba C, et al. Obstructive sleep apnea and obesity are associated with reduced GPR 120 plasma levels in children[J]. Sleep, 2014, 37(5): 935-941.
37 Giorgio Z, Federica C, Fleur B, et al. Osteoprotegerin increases leukocyte adhesion to endothelial cells both in vitro and in vivo[J]. Blood, 2007, 110(2): 536-543.
38 Marshall NS, Wong KK, Liu PY, et al. Sleep apnea as an independent risk factor for all-cause mortality: the Busselton Health Study [J]. Sleep, 2008, 31(8): 1079-1085.
39 Wen WW, Ning Y, Zhang Q, et al. TNFRSF11B: A potential plasma biomarker for diagnosis of obstructive sleep apnea [J]. Clin Chim Acta, 2019, 490: 39-45.
40 Suleyman A, Tuncay K, Suna A, et al. Expression of adropin in rat brain, cerebellum, kidneys, heart, liver, and pancreas in streptozotocin-induced diabetes [J]. Mol Cell Biochem, 2013, 380(1-2): 73-81.
41 Xavier C, Vera B. Chronic inflammatory diseases and endothelial dysfunction [J]. Aging Dis, 2016, 7(1): 81-89.
42 Fan ZW, Zhang Y, Zou FF, et al. Serum adropin level is associated with endothelial dysfunction in patients with obstructive sleep apnea and hypopnea syndrome [J]. Sleep Breath, 2021, 25(1): 117-123.
43 Nitish RM. Catestatin is a novel endogenous peptide that regulates cardiac function and blood pressure [J]. Cardiovasc Res, 2008, 80(3): 330-338.
44 Josip AB, Zoran D, Daniela SD, et al. Catestatin serum levels are increased in male patients with obstructive sleep apnea[J]. Sleep Breath, 2019, 23(2): 473-481.

备注/Memo

备注/Memo:
基金项目: 青海大学附属医院中青年科研基金一般项目(ASRF-2017-YB-12)
通信作者: 赵玲莉, Email: zhaolingli640521@163.com
更新日期/Last Update: 2022-02-20